Doctors now use the Revised International Staging System (R-ISS) to classify multiple myeloma, which divides the disease into three distinct stages. This staging system is based on several factors including:
• Blood test results
• Protein levels
• Genetic changes in cancer cells Unlike other cancers where staging is based Show Full Answer
Doctors now use the Revised International Staging System (R-ISS) to classify multiple myeloma, which divides the disease into three distinct stages. This staging system is based on several factors including:
• Blood test results
• Protein levels
• Genetic changes in cancer cells Unlike other cancers where staging is based on tumor size and spread, multiple myeloma staging is unique because it's a blood cancer that is systemic by nature. The staging focuses on factors like:
• Bone damage
• Beta-2 microglobulin (B2M) levels
• Abnormal protein levels
This helps doctors guide treatment decisions, though staging provides less direct information about prognosis compared to solid tumors.
August 18, 2025